Sponsored by
Wanhuida Intellectual Property
Revised examination guidelines and evolving technology have driven a surge in smart medicine patent filings and grants. Jie Zhao of Wanhuida Intellectual Property examines several examples of significance for foreign applicants
Sofie McPherson says she is excited to work at a firm that offers an integrated approach between attorneys and litigators
Lawyers at Carpmaels & Ransford explain how the healthcare sector has not simply participated in the UPC’s early years, but actively shaped it
The firm has hired former in-house counsel Quintin Cassady to lead the launch of the new office
Shaina Haria, a final-seat trainee at an international law firm’s UK office, shares how she fell in love with IP and why the area of law has changed the way she views the world
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
US law firms highlight litigation profitability and client demand as driving forces behind a boom in lateral hires in the life sciences sector
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Sponsored
Sponsored
-
Sponsored by CASAn effective intellectual property strategy helps green chemistry companies reduce R&D risk, secure competitive advantage, and translate scientific innovation into sustainable commercial success, as explained by CAS
-
Sponsored by CASCAS outlines how intellectual property practitioners can combine multi-source research, advanced techniques, and AI tools to uncover prior art and strengthen legal analysis
-
Sponsored by Becerril, Coca & BecerrilSoledad Betanzos-Lara of Becerril, Coca & Becerril explains how Mexico’s pharmaceutical and biotech patentability criteria are being reshaped by evolving examination practice
Sponsored by
CAS
CAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
Sponsored by
CAS
CAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
Sponsored by
Wanhuida Intellectual Property
Revised examination guidelines and evolving technology have driven a surge in smart medicine patent filings and grants. Jie Zhao of Wanhuida Intellectual Property examines several examples of significance for foreign applicants
Sponsored by
Wanhuida Intellectual Property
Honghui Hu of Wanhuida Intellectual Property examines three CNIPA invalidation decisions that provide valuable insights into how Swiss‑type claims are interpreted in China, with claim wording, efficacy, and prosecution strategy of critical importance
Interviews; Exclusives
Interviews; Exclusives
Natasha Daughtrey shares how firms can help their women litigators take the lead on trials, and why she is seeing a convergence of tech and life sciences disputes
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
In an exclusive interview, Rouse CEO Luke Minford, Arnold & Siedsma managing partner Steve Duxbury, and Wrays executive chairman Gary Cox discuss plans to build the world’s first ‘truly integrated’ global IP services business
The firm has added six practitioners in recent weeks as it takes measured steps to build its IP practice with a focus on trade secrets work
Daralyn Durie discusses the ‘amazing’ opportunity of working on an AI case, the value of celebrating women, and how to build the next wave of talent
-
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
Practitioners and law firms should keep their eyes peeled as the shortlist for our annual Awards is set to be released